Covered recipient · General Payments record
JAMES SAMUEL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$195,426.15
- Reported across 238 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $32,219.29 | 48 |
| Food and Beverage | $121.83 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $32,219.29 | 48 |
| Acerta Pharma LLC | $121.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (49)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $754.55 | 01/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011257 | CMS |
| ABBVIE INC. | $603.64 | 01/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011259 | CMS |
| ABBVIE INC. | $603.64 | 01/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011261 | CMS |
| ABBVIE INC. | $830.01 | 01/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011263 | CMS |
| ABBVIE INC. | $603.64 | 02/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011265 | CMS |
| ABBVIE INC. | $603.64 | 02/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011267 | CMS |
| ABBVIE INC. | $603.64 | 02/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011269 | CMS |
| ABBVIE INC. | $603.64 | 02/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011271 | CMS |
| ABBVIE INC. | $603.64 | 03/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011273 | CMS |
| ABBVIE INC. | $603.64 | 03/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011275 | CMS |
| ABBVIE INC. | $2,263.65 | 03/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011277 | CMS |
| ABBVIE INC. | $603.64 | 04/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011279 | CMS |
| ABBVIE INC. | $603.64 | 04/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011281 | CMS |
| ABBVIE INC. | $603.64 | 04/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011283 | CMS |
| ABBVIE INC. | $603.64 | 04/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011285 | CMS |
| ABBVIE INC. | $603.64 | 04/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011287 | CMS |
| ABBVIE INC. | $603.64 | 05/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011289 | CMS |
| ABBVIE INC. | $603.64 | 05/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011291 | CMS |
| ABBVIE INC. | $603.64 | 05/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011293 | CMS |
| ABBVIE INC. | $603.64 | 05/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011295 | CMS |
| ABBVIE INC. | $603.64 | 06/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011297 | CMS |
| ABBVIE INC. | $603.64 | 06/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011299 | CMS |
| ABBVIE INC. | $603.64 | 06/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011301 | CMS |
| ABBVIE INC. | $603.64 | 06/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011303 | CMS |
| ABBVIE INC. | $603.64 | 07/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011305 | CMS |
| ABBVIE INC. | $603.64 | 07/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011307 | CMS |
| ABBVIE INC. | $603.64 | 07/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011309 | CMS |
| ABBVIE INC. | $603.64 | 08/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011311 | CMS |
| ABBVIE INC. | $603.64 | 08/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011313 | CMS |
| ABBVIE INC. | $603.64 | 08/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011315 | CMS |
| ABBVIE INC. | $603.64 | 08/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011317 | CMS |
| ABBVIE INC. | $603.64 | 09/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011319 | CMS |
| ABBVIE INC. | $603.64 | 09/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011321 | CMS |
| ABBVIE INC. | $603.64 | 09/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011323 | CMS |
| ABBVIE INC. | $603.64 | 09/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011325 | CMS |
| ABBVIE INC. | $603.64 | 09/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011327 | CMS |
| ABBVIE INC. | $603.64 | 10/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011329 | CMS |
| ABBVIE INC. | $603.64 | 10/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011331 | CMS |
| ABBVIE INC. | $603.64 | 10/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011333 | CMS |
| ABBVIE INC. | $603.64 | 10/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011335 | CMS |
| ABBVIE INC. | $603.64 | 11/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011337 | CMS |
| ABBVIE INC. | $603.64 | 11/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011339 | CMS |
| ABBVIE INC. | $603.64 | 11/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011341 | CMS |
| ABBVIE INC. | $1,207.28 | 12/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011343 | CMS |
| ABBVIE INC. | $1,207.28 | 12/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011345 | CMS |
| ABBVIE INC. | $603.64 | 12/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011347 | CMS |
| ABBVIE INC. | $603.64 | 12/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011349 | CMS |
| ABBVIE INC. | $603.64 | 12/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106011351 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.83 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104774646 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.